This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988 Apr;14(2):101-10.

Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future

B B Kroon¹

Affiliations

PMID: 3360151

Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future

B B Kroon. Eur J Surg Oncol. 1988 Apr.

. 1988 Apr;14(2):101-10.

Author

B B Kroon¹

Affiliation

¹ Department of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), Amsterdam.

PMID: 3360151

No abstract available

PubMed Disclaimer

Similar articles

[Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
Kettelhack C, Hohenberger P, Schlag PM. Kettelhack C, et al. Langenbecks Arch Chir Suppl Kongressbd. 1996;113:127-9. Langenbecks Arch Chir Suppl Kongressbd. 1996. PMID: 9101810 German.
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM, Vrouenraets BC, van Geel BN, Eggermont AM, Klaase JM, Nieweg OE, Kroon BB. Klop WM, et al. J Am Coll Surg. 1996 Jun;182(6):467-72. J Am Coll Surg. 1996. PMID: 8646345
Isolation limb perfusion for melanoma: current trends and future directions.
Coit DG. Coit DG. Melanoma Res. 1994 Mar;4 Suppl 1:57-60. Melanoma Res. 1994. PMID: 8038599 Review.
Is there any reason to delay introduction of tumor necrosis factor in the management of in-transit metastasis of unresectable melanoma?
Garrido-Laguna I, Ponz M, Espinós J. Garrido-Laguna I, et al. J Clin Oncol. 2007 Mar 20;25(9):1149; author reply 1149-51. doi: 10.1200/JCO.2006.09.4862. J Clin Oncol. 2007. PMID: 17369585 No abstract available.
Isolated limb perfusion for melanoma.
Kroon BB, Noorda EM, Vrouenraets BC, van Slooten GW, Nieweg OE. Kroon BB, et al. Surg Oncol Clin N Am. 2008 Oct;17(4):785-94, viii-ix. doi: 10.1016/j.soc.2008.04.005. Surg Oncol Clin N Am. 2008. PMID: 18722918 Review.

See all similar articles

Cited by

Therapeutic isolated limb perfusion (ILP) in the management of patients with advanced or recurrent limb melanoma.
Khan MA, Lanitis S, Desai AP, Rosin RD. Khan MA, et al. Ir J Med Sci. 2012 Mar;181(1):157. doi: 10.1007/s11845-011-0764-7. Epub 2011 Sep 29. Ir J Med Sci. 2012. PMID: 21959950 No abstract available.
Molecular Aspects of the Isolated Limb Infusion Procedure.
Teras J, Carr MJ, Zager JS, Kroon HM. Teras J, et al. Biomedicines. 2021 Feb 7;9(2):163. doi: 10.3390/biomedicines9020163. Biomedicines. 2021. PMID: 33562337 Free PMC article. Review.
Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.
Schraffordt Koops H, Kroon BB, Oldhoff J, Hoekstra HJ. Schraffordt Koops H, et al. World J Surg. 1992 Mar-Apr;16(2):241-5. doi: 10.1007/BF02071527. World J Surg. 1992. PMID: 1561805
Rapid measurement of blood leakage during regional chemotherapy.
Alexander C, Omlor G, Berberich R, Gross G, Feifel G. Alexander C, et al. Eur J Nucl Med. 1993 Mar;20(3):187-91. doi: 10.1007/BF00169996. Eur J Nucl Med. 1993. PMID: 8385020
Technique and results of regional hyperthermic cytostatic arm perfusion for malignant melanoma.
Würl P, Eichfeld U, Pauer HD, Gläser A, Rose U, Dralle H. Würl P, et al. Surg Today. 1997;27(8):719-25. doi: 10.1007/BF02384984. Surg Today. 1997. PMID: 9306586

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information